Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | EVP, Chief Information Officer | May 29, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,546 |
Ending reported balance
After 2026-05-31 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-05-29 · Grant · Acquired 2,534 · Balance 9,915 F1: Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030. Row 2 · 2026-05-30 · Tax withholding · Disposed 305 · Balance 9,610 Row 3 · 2026-05-31 · Tax withholding · Disposed 64 · Balance 9,546 |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2026 Filed Jun 2, 2026 20:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 64 | $180.71 | $11,565.44 |
DisclosureSEC source: 0001100682-26-000099 · form4.xml · nonDerivative · entry 3 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,546 Read SEC document |
| May 30, 2026 Filed Jun 2, 2026 20:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 305 | $180.71 | $55,116.55 |
DisclosureSEC source: 0001100682-26-000099 · form4.xml · nonDerivative · entry 2 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,610 Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:42 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,534 | $180.71 | $457,919.14 |
DisclosureSEC source: 0001100682-26-000099 · form4.xml · nonDerivative · entry 1 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,915 F1 · shares: Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030. Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 47 | $156.73 | $7,366.31 |
DisclosureSEC source: 0001100682-26-000081 · form4.xml · nonDerivative · entry 2 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,381 Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 64 | $160.30 | $10,259.20 |
DisclosureSEC source: 0001100682-26-000081 · form4.xml · nonDerivative · entry 1 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,428 Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 655 | $211.68 | $138,650.40 |
DisclosureSEC source: 0001100682-26-000006 · form4.xml · nonDerivative · entry 2 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,492 Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:36 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000006 · form4.xml · nonDerivative · entry 1 Mintz Mark · CIK 0002071546 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,147 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.